Dimetridazole

Dimetridazole (CAS No.: 551-92-8) is a nitroimidazole-class antimicrobial agent widely utilized in biomedical research for its activity against anaerobic bacteria and protozoa, serving as a model compound for studying antimicrobial mechanisms and antivirulence strategies. It exerts its biological effects in part by inhibiting microbial protein synthesis and disrupting cellular membrane integrity, while also modulating quorum sensing pathways through interactions with regulatory systems such as LasR, RhlR, and PqsR, leading to suppression of virulence factor production and biofilm formation. Additionally, transcriptomic and mechanistic studies indicate downregulation of fatty acid biosynthesis-associated genes, contributing to compromised membrane function in susceptible organisms. In vitro activity is strain-dependent, with antimicrobial effects typically observed at micromolar to high micromolar concentrations, and it has demonstrated the capacity to potentiate the efficacy of other antimicrobial agents, including β-lactams and membrane-targeting antibiotics, in multidrug-resistant bacterial models. Dimetridazole is also employed in electrochemical sensing research due to its detectable redox properties at nanomolar to micromolar levels. Experimental applications include bacterial culture assays, quorum sensing inhibition studies, and infection models in invertebrates and rodents, where dosing regimens vary according to specific study designs. Owing to its genotoxic profile and regulatory restrictions in food-producing contexts, its use is limited to controlled laboratory investigations focused on antimicrobial resistance, microbial pathogenesis, and drug combination screening.